Clinically isolated syndromes (CIS), such as optic neuritis, brainstemor spinal cord syndromes are frequently the first clinical presentations of multiple sclerosis. However, not all CIS patients develop multiple sclerosis and in those who do, disability is highly variable. In previous follow-up studies, brain lesions onT2-weighted MRI are associated with increased risk of multiple sclerosis and to an extent disability.We evaluated the longitudinal rela-tionships between the MRI lesions and clinical course over a period of 20 years. CIS patients were recruited between1984 and1987 and previously followed up after 1, 5, 10 and14 years.Of the 140 subjects whowere initially recruited with a CIS for a baseline MRI study, we followed up 107 patie...
Magnetic resonance imaging (MRI) is the key prognostic tool in people with a clinically isolated syn...
Magnetic resonance (MR) imaging is very sensitive in showing disseminated MS lesions. Subclinical MR...
Methodological challenges limit the use of brain atrophy and lesion burden measures in the follow-up...
Clinically isolated syndromes (CIS), such as optic neuritis, brainstemor spinal cord syndromes are f...
Clinically isolated syndromes (CIS), such as optic neuritis, brainstem or spinal cord syndromes are ...
Background and purpose: To assess the predictive value of T2 lesions on the rate of progression of d...
Many studies report an overlap of MRI and clinical findings between patients with relapsing-remittin...
Wybrecht, Delphine Reuter, Francoise Zaaraoui, Wafaa Faivre, Anthony Crespy, Lydie Rico, Audrey Mali...
OBJECTIVES: To explore the relationship between slowly expanding lesions (SELs) on MRI and disabilit...
BACKGROUND: MRI findings influence the risk of patients with optic neuritis (ON) developing clinical...
The accrual of brain focal pathology is considered a good substrate of disability in relapsing-remit...
The clinical course of relapse-onset multiple sclerosis is highly variable. Demographic factors, cli...
Background: Natural history studies have suggested that the disability progression due to multiple s...
Spinal cord pathology is an important substrate for long-term disability in multiple sclerosis (MS)....
Background: Gray matter (GM) and white matter (WM) pathology has an important role in disease progre...
Magnetic resonance imaging (MRI) is the key prognostic tool in people with a clinically isolated syn...
Magnetic resonance (MR) imaging is very sensitive in showing disseminated MS lesions. Subclinical MR...
Methodological challenges limit the use of brain atrophy and lesion burden measures in the follow-up...
Clinically isolated syndromes (CIS), such as optic neuritis, brainstemor spinal cord syndromes are f...
Clinically isolated syndromes (CIS), such as optic neuritis, brainstem or spinal cord syndromes are ...
Background and purpose: To assess the predictive value of T2 lesions on the rate of progression of d...
Many studies report an overlap of MRI and clinical findings between patients with relapsing-remittin...
Wybrecht, Delphine Reuter, Francoise Zaaraoui, Wafaa Faivre, Anthony Crespy, Lydie Rico, Audrey Mali...
OBJECTIVES: To explore the relationship between slowly expanding lesions (SELs) on MRI and disabilit...
BACKGROUND: MRI findings influence the risk of patients with optic neuritis (ON) developing clinical...
The accrual of brain focal pathology is considered a good substrate of disability in relapsing-remit...
The clinical course of relapse-onset multiple sclerosis is highly variable. Demographic factors, cli...
Background: Natural history studies have suggested that the disability progression due to multiple s...
Spinal cord pathology is an important substrate for long-term disability in multiple sclerosis (MS)....
Background: Gray matter (GM) and white matter (WM) pathology has an important role in disease progre...
Magnetic resonance imaging (MRI) is the key prognostic tool in people with a clinically isolated syn...
Magnetic resonance (MR) imaging is very sensitive in showing disseminated MS lesions. Subclinical MR...
Methodological challenges limit the use of brain atrophy and lesion burden measures in the follow-up...